PAUWELS ERIC (Chief Business Officer) sold 8.4% of their position (7.35K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $565.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 1/12/2026ACC: 0001323212-26-000006
Officer· Chief Business Officer
Since Apr 2020
-7.35K
Net shares
Net seller
$565.9K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
7.35K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−2.56K
Price / share
$76.42
Trade value
$195.71K
% of position
2.9%
1/8/2026
87.49K→84.93K
Common Stock
Direct
Shares
−587.00
Price / share
$76.98
Trade value
$45.19K
% of position
0.7%
1/8/2026
84.93K→84.34K
Common Stock
Direct
Shares
−1.45K
Price / share
$76.45
Trade value
$111.16K
% of position
1.7%
1/8/2026
84.34K→82.89K
Common Stock
Direct
Shares
−1.72K
Price / share
$77.41
Trade value
$133.30K
% of position
2.1%
1/9/2026
82.89K→81.17K
Common Stock
Direct
Shares
−1.02K
Price / share
$78.70
Trade value
$80.59K
% of position
1.3%
1/12/2026
81.17K→80.14K
Total
Net shares
−7.35K
Net value
-$565.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/8/2026 | S · Sale | −2.56K | $76.42 | $195.71K | 2.9% | 87.49K | 84.93K |
| Common Stock Direct | 1/8/2026 | S · Sale | −587.00 | $76.98 | $45.19K | 0.7% | 84.93K | 84.34K |
| Common Stock Direct | 1/8/2026 | S · Sale | −1.45K | $76.45 | $111.16K | 1.7% | 84.34K | 82.89K |
| Common Stock Direct | 1/9/2026 | S · Sale | −1.72K | $77.41 | $133.30K | 2.1% | 82.89K | 81.17K |
| Common Stock Direct | 1/12/2026 | S · Sale | −1.02K | $78.70 | $80.59K | 1.3% | 81.17K | 80.14K |
| Total | −7.35K | -$565.95K | ||||||
Derivative Transactions0
No derivative transactions reported